Clinical Trial Update: Phase 3 Trial to Evaluate the Efficacy and Safety of LC15-0444 in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of LC15-0444 in patients with Type 2 Diabetes Mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• LC15-0444

Snippet

Sponsor: LG Life Sciences | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED